Gradia Health

Gradia Health, based in San Francisco, CA, provides an integrated concierge care platform that helps clinics deliver personalized, high-touch care to patients with chronic GI conditions like IBS and GERD. The company has raised $4.2 million in total seed funding, including a July 2023 round led by MaC Venture Capital, with participation from Y Combinator and Soma Capital. Notable angel investors include Gene Lee (Ramp), Eric Feldman (Bolt), and David Tsao (BillionToOne). Its software empowers patients to track care status, communicate with providers, and access specialized virtual care teams such as dietitians and nurses between in-person visits, improving patient outcomes and clinic revenue. Founded in 2021 by Rithvik Seela and Andrew Zelaya, Gradia Health currently employs 7 individuals and serves thousands of patients through its clinic partnerships, with plans to triple its patient base by the end of 2023.

High-Level Overview

Gradia Health is a healthcare technology company that builds an integrated, concierge care platform designed to deliver personalized, high-touch healthcare at scale, primarily targeting patients with chronic conditions. Its software empowers patients to stay informed about their care, communicate directly with providers, and access specialized virtual care teams including dietitians and nurses. By augmenting traditional clinics with virtual care capabilities, Gradia helps healthcare providers serve more patients while improving care quality and increasing clinic revenue. The company currently operates in several clinics across the Southeastern United States and aims to become the gold standard for chronic condition management through continuous innovation and expansion[1][2][3][4].

Origin Story

Founded in 2021 by Stanford computer science graduates Rithvik Seela (CEO) and Andrew Zelaya (CTO), Gradia Health emerged from their desire to challenge outdated healthcare conventions and improve patient outcomes through technology. Their backgrounds in computer science and economics at Stanford informed the creation of a platform that integrates virtual care teams with existing clinics, addressing gaps in chronic disease management. Early traction includes backing by Y Combinator and major venture capital firms, as well as partnerships with multi-provider clinics serving thousands of patients with chronic gastrointestinal conditions like IBS and GERD. A pivotal moment was securing $4.2 million in funding in 2023 to accelerate growth and product development[1][2][4].

Core Differentiators

• Integrated Virtual Care Teams: Gradia facilitates the creation and management of specialized virtual care teams that work alongside physicians, enhancing continuous patient support between in-person visits.
• Physician Empowerment: Unlike competitors that replace providers, Gradia amplifies physicians’ capabilities, enabling them to serve more patients without compromising care quality.
• Seamless Clinic Integration: The platform integrates smoothly with existing clinic workflows and protocols, deploying engineers on-site to customize and optimize performance.
• Patient-Centric Communication: Enables direct, straightforward communication between patients and care teams, keeping patients informed and engaged.
• Security and Compliance: Provides enterprise-grade security tailored for healthcare environments, ensuring patient safety and regulatory adherence[2][5][6].

Role in the Broader Tech Landscape

Gradia rides the growing trend of virtual and integrated healthcare solutions aimed at managing chronic diseases more effectively. The timing is critical as the U.S. faces a rising burden of chronic conditions affecting 60-70 million Americans, alongside increasing demand for personalized, continuous care outside traditional clinical settings. Market forces such as telehealth adoption, value-based care models, and digital health innovation favor platforms like Gradia that enhance clinic efficiency and patient outcomes. By bridging virtual care with brick-and-mortar clinics, Gradia influences the ecosystem by setting new standards for integrated, high-touch care delivery[2][3][4].

Quick Take & Future Outlook

Looking ahead, Gradia aims to triple its patient base within the near term and expand its team and care pathways across multiple specialties. The company’s future trajectory will be shaped by trends in chronic disease management, telehealth integration, and healthcare digitization. As it scales, Gradia’s influence may extend beyond gastroenterology to become a foundational platform for managing diverse chronic conditions, potentially transforming how clinics deliver continuous, personalized care at scale. This aligns with its mission to challenge archaic healthcare conventions and make attentive, patient-centered care the norm[2][4].